Looking for a related edition? Cancer Research, Statistics, and Treatment (ISSN 2590-3233)

Cancer Research Journal Citation Rate 2026

ISSN 0008-5472 eISSN 1538-7445 American Association for Cancer Research US

Q3 Quartile

About Cancer Research
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Cancer Research (CR) is a peer-reviewed academic journal covering Cancer Genomics and Diagnostics and Cancer Immunotherapy and Biomarkers, published by American Association for Cancer Research in US, catalogued under ISSN 0008-5472 (e-ISSN 1538-7445). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.46 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.

Authors typically receive a first decision in around 96 days.

Cancer Research Citation Rate 2026 — In Context

Cancer Research has a 2025 2-Year Citation Rate (OpenAlex) of 0.46, placing it in the Q3 quartile within the Cancer Genomics and Diagnostics research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Cancer Research operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view. Average submission-to-decision turnaround is approximately 96 days.

Researchers looking to publish in Cancer Research should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Cancer Research against similar journals in the field, use our journal comparison tool.

Submission Tips for Cancer Research
  • Be prepared for a longer review cycle — decisions typically take around 96 days.
  • This journal covers Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Cancer Research Compares
Citation Rate vs Field Avg
-86%
Field avg: 3.32

Compared against 10 journals in the same research areas.

ISSN (Print) 0008-5472
ISSN (Online) 1538-7445
Publisher American Association for Cancer Research
Country United States
APC / Cost Inquire with Publisher
Review Speed ~96 days to first decision
In-depth profile & metrics

Cancer Research is published by American Association for Cancer Research and based in United States.

In our subject taxonomy, Cancer Research is classified under Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments and Cancer, Hypoxia, and Metabolism.

For prospective authors, Cancer Research returns a first decision in about 96 days (longer for its field).

Its most recent citation rate stands at 0.464.

Research Areas
Links
Frequently Asked Questions about Cancer Research

Cancer Research does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 0.464 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Cancer Research is not an open access journal.

The average time from submission to first decision at Cancer Research is approximately 96 days.

Cancer Research is published by American Association for Cancer Research.

Cancer Research is not currently listed in the major indexes we track (Scopus, DOAJ, Web of Science). This is not evidence of predatory practice — many legitimate new or regional journals are not yet indexed — but you should verify its peer-review process, editorial board, and indexing directly with the publisher before submitting.

The ISSN of Cancer Research is 0008-5472. Its electronic ISSN (eISSN) is 1538-7445.

Cancer Research sits in the Q3 quartile based on its latest impact factor of 0.46, ranked across all journals in our database.
Live Indexing Status
Updated July 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Unverified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
0.464
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 0.464 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Journal Metrics
96
Days to Decision

Related Journals in Your Field

Metadata

Last updated: Jul 12, 2026

Updated by: system

Get weekly updates for Cancer Genomics and Diagnostics journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google